
We have been writing about conflicts of interest in health care now for a long time. We started with a focus on academic physicians' ...
We have been writing about conflicts of interest in health care now for a long time. We started with a focus on academic physicians' ...
Pay-for-performance has been a persistently fashionable mantra for health care business leaders and policy advocates, particularly as applie...
Everyone loves a parade, and so the parade of legal settlements by prominent health care organizations continues. The latest to march into...
In my July 2010 post " Meaningful Use Final Rule" I pointed out the cart-before-the-horse problem of creating "meaningful use...
Back in January, 2010, we posted about Novartis' settlement of charges that it promoted its anti-seizure drug, Trileptal, (Oxcarbazepin...
For five years now, we have been writing about concentration and abuse of power in health care, and on specific tactics used predominantly b...
I have collected another series of stories from the wild and wacky world of health care executive compensation. These are from three differ...